Initial therapeutic approach with pembrolizumab in synchronous multiple cancers, including non-small cell lung cancer highly positive for programmed death-ligand 1 expression

Koizumi, T; Kanda, S; Kobayashi, T; Iwasa, Y; Matsuo, A

Koizumi, T (通讯作者),Shinshu Univ, Dept Hematol & Med Oncol, Sch Med, 3-1-1 Asahi Matsumoto, Matsumoto, Nagano 3908621, Japan.

CHEMOTHERAPY, 2023; 68 (3): 160

Abstract

Treatment of synchronous multiple primary cancers is clinically difficult. We report four cases of synchronous primary cancers, including advanced and......

Full Text Link